Post Cardiac Arrest Care - European Resuscitation Council and European Society of Intensive Care Medicine 2021 Guidelines for Post-resuscitation Care
This section is focused on excerpts of pharmacotherapy recommendations discussed on the European Resuscitation Council and European Society of Intensive Care Medicine 2021 Guidelines for Post-resuscitation Care (1).
To ensure a comprehensive understanding of post cardiac arrest care please read the open access full text.
Post-resuscitation care (post cardiac arrest care) Algorithm (1)
Hemodynamic, oxygenation and ventilation targets
Figure 2. Hemodynamic, oxygenation and ventilation targets (1).
Guideline updates - Blood pressure target
Haemodynamic monitoring and management (1)
All patients should be monitored with an arterial line for continuous blood pressure measurements, and it is reasonable to monitor cardiac output in hemodynamically unstable patients.
Perform early (as soon as possible) echocardiography in all patients to detect any underlying cardiac pathology and quantify the degree of myocardial dysfunction.
Avoid hypotension (<65 mmHg). Target mean arterial pressure (MAP) to achieve adequate urine output (>0.5 mL kg/h ) and normal or decreasing lactate. During TTM at 33º C, bradycardia may be left untreated if blood pressure, lactate, ScvO2 or SvO2 is adequate. If not, consider increasing the target temperature, but to no higher than 36º C.
Maintain perfusion with fluids, noradrenaline and/or dobutamine, depending on individual patient need for intravascular volume, vasoconstriction or inotropy.
Do not give steroids routinely after cardiac arrest. Avoid hypokalemia, which is associated with ventricular arrhythmias.
Guideline updates - Treatment of seizures
Seizure control (1)
Use electroencephalography (EEG) to diagnose electrographic seizures in patients with clinical convulsions and to monitor treatment effects.
Guidelines recommend levetiracetam or sodium valproate as first-line antiepileptic drugs, in addition to sedative drugs, to treat seizures after cardiac arrest.
Routine seizure prophylaxis is not recommended in post-cardiac arrest patients.
Guideline updates - Treatment of seizures
Seizure control (1)
Use electroencephalography (EEG) to diagnose electrographic seizures in patients with clinical convulsions and to monitor treatment effects.
Guidelines recommend levetiracetam or sodium valproate as first-line antiepileptic drugs, in addition to sedative drugs, to treat seizures after cardiac arrest.
Routine seizure prophylaxis is not recommended in post-cardiac arrest patients.
Guideline updates - General intensive care management
General intensive care management (1)
Use short acting sedatives and opioids.
Avoid using a neuromuscular blocking drug routinely in patients undergoing TTM, but it may be considered in case of severe shivering during TTM.
Provide stress ulcer prophylaxis routinely in cardiac arrest patients.
Provide deep venous thrombosis prophylaxis.
Target a blood glucose of 140-180 mg/dL using an infusion of insulin if required; avoid hypoglycemia (<70 mg/dL).
Start enteral feeding at low rates (trophic feeding) during TTM and increase after rewarming if indicated. If TTM of 36 C is used as the target temperature, gastric feeding rates may be increased early during TTM.
We do not recommend using prophylactic antibiotics routinely.
Related drugs
Sedatives / analgesia
Fentanyl
Propofol
Alfentanil
Remifentanil
Vasopressors / inotropes
Neuromuscular blockade
Rocuronium
Cisatracurium
Seizure control
Sodium valproate
Stress ulcer prophylaxis
Omeprazole
Esomeprazole
Deep venous thrombosis prophylaxis
Unfractionated heparin
Enoxaparin
Dalteparin
Bivalirudin
Fondaparinux
References
Nolan JP, Sandroni C, Böttiger BW, et al. European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care. Intensive Care Med. 2021;47(4):369-421. doi:10.1007/s00134-021-06368-4
Springer - Intensive Care Medicine (Open Access)
Further reading on post cardiac arrest care
AHA Guidalines on post-cardiac arrest care
Callaway CW, Donnino MW, Fink EL, et al. Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care [published correction appears in Circulation. 2017 Sep 5;136(10 ):e197]. Circulation. 2015;132(18 Suppl 2):S465-S482. doi:10.1161/CIR.0000000000000262
Circulation (Open Access)
Seizure Prophylaxis
Cronberg T, Skrifvars M, Nolan J, Andersen LW, Berg KM, Böttiger BW, Callaway CW, Deakin CD, Donnino MW, Drennan I, Hsu C, Morely P, Nicholson TC, O’Neil BJ, Paiva EF, Parr MJ, Reynolds JC, Sandroni C, Soar J, Wang TL, Welsford M, Neumar RW. Post-Cardiac Arrest Seizure Prophylaxis and Treatment Consensus on Science with Treatment Recommendations [Internet] Brussels, Belgium: International Liaison Committee on Resuscitation (ILCOR) Advanced Life Support Task Force, 2020 January 5th. Accessed March 11, 2023.
ILCOR (Open Access)
Prophylactic antibiotics
Couper K, Yeung K, Soar J, Berg K, Andersen LW, Böttiger BW, Callaway CW, Deakin CD, Donnino M, Drennan I, Hsu CH, Morley PT, Neumar RW, Nicholson TC, O’Neil BJ, Paiva EF, Parr MJ, Reynolds JC, Sandroni C, Wang TL, Welsford M, Nolan JP. Prophylactic antibiotics following return of spontaneous circulation in adults: Consensus on Science with Treatment Recommendations [Internet] Brussels, Belgium: International Liaison Committee on Resuscitation (ILCOR) Advanced Life Support Task Force, 3 January 2020. Accessed March 11, 2023.
ILCOR (Open Access)
® 2023 EMDrugs. All rights reserved.
contact@emdrugs.com
DISCLAIMER
⚠ This website provides general information and discussion about medications, health, and related subjects. The words and other content provided in this website, and in any linked materials, are not intended and should not be construed as medical advice. If the reader or any other person has a medical concern, he or she should consult with an appropriately-licensed physician or other legally accredited health care worker in the country that resides or is visiting.
Please do not delay your medical concerns and potential health emergencies by searching information in this website, instead look out for medical opinion in the services that exist with that specific purpose and work under the respective local health-care regulations.
The views expressed on this blog and website have no relation to those of any academic, hospital, practice or other institution with which the authors are affiliated.
For other instances, the authors of this website do not have any conflict of interest with any institution or pharmaceutical company in particular, and do not receive any compensation about any licenced drug mentioned in the website. In the same matter, the website is not intended to recommend any specific patented medication.
EMDrugs Team